Leucemia mieloide acuta: le nuove terapie ampliano le possibilità di cura

Acute myeloid leukemia is a rare and aggressive disease that primarily affects older adults. In recent years, the emergence of new therapeutic strategies has profoundly changed the landscape, expanding the number of patients eligible for curative care. What innovations have changed clinical practice? And how has the management of older patients evolved compared to the past? We spoke with Alessandro Rambaldi, Professor of Hematology and Scientific Director of the FROM Foundation – Papa Giovanni XXIII Hospital in Bergamo, whom we met on the occasion of AIL National Day – Research and Treatment in Hematology: AIL's Commitment Between Present and Future.